ProCE Banner Activity

A Year in Review: ADCs Targeting HER2 in NSCLC

Slideset

Download these slides for an expert’s perspective on how to integrate HER2-directed antibody–drug conjugates into management of advanced HER2-mutated NSCLC.

Released: January 29, 2024

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.